Skip to main content
OpenTrials

Clinical trial condition

Diabetes

Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.

2,489 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Diabetes trial results

Completed

Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes

NCT00982228

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Peoria, Arizona, United States
  • Novo Nordisk Investigational Site Concord, California, United States
View all 91 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes

NCT00972283

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Alexander City, Alabama, United States
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Peoria, Arizona, United States
View all 136 locations
View Trial Details
Completed

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

NCT01059799

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Shatin, New Territories, Hong Kong
  • Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Kamakura-shi, Kanagawa, Japan
  • Novo Nordisk Investigational Site Kawasaki-shi, Japan
View all 53 locations
View Trial Details
Completed

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

NCT00773279

Conditions
Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
Locations
  • Novo Nordisk Investigational Site Burlingame, California, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Encino, California, United States
  • Novo Nordisk Investigational Site Escondido, California, United States
View all 65 locations
View Trial Details

Related conditions